Biotechnology CRISPR may not cause hundreds of rogue mutations after all Researchers behind a controversial paper have admitted that their results may be wrong. by Emily Mullin 2018-03-30T16:41:00-04:00
Rewriting Life Gene-Editing Companies Hit Back at Paper That Criticized CRISPR Report that suggested CRISPR is too dangerous to use as a drug was wrong, say biotech companies. by Antonio Regalado 2017-06-09T13:13:00-04:00
Biotechnology Who Owns the Biggest Biotech Discovery of the Century? There’s a bitter fight over the patents for CRISPR, a breakthrough new form of DNA editing. by Antonio Regalado 2014-12-04T18:00:00-05:00
